2023年國際 SCI 論文
| 編號 | 篇名 | 作者 | 期刊 | 卷期 |
| 1 | Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation |
Yu HT, Chen KH, Lin CJ, Hsu CC, Chang YL | Heliyon | 2023;9(3):e14456 |
| 2 | Hypoglycemia risk with inappropriate dosing of glucose-lowering drugs in patients with chronic kidney disease: a retrospective cohort study | Li YJ, Chang YL, Chou YC, Hsu CC | Sci Rep | 2023;13(1):6373 |
| 3 | A retrospective cohort study on the cardiotoxicity incidence rates of immune checkpoint inhibitors for oncology patients | Ho CC, Wu SL, Tsai HY, Hu YW, Chang YL | J Chin Med Assoc | 2023; 86(5):499-505 |
| 4 | The Clinical Benefits of Antiresorptive Agents in Primary Breast Cancer Patients Receiving Adjuvant Endocrine Therapy: A Systematic Review with Pairwise and Network Meta-analysis | Wang SF, Lin YS, Yeh WY, Chang YL, Chiang CE, Chen CH, Tseng LM, Lee HC, Liu CY, Cheng HM | J Clin Endocrinol Metab | 2023;108(11):e1433-e1447 |
| 5 | Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer | Wang SF, Chang YL, Fang Wl, Li AFY, Chen CF, Yeh TS, Hung GY, Huang KH, Lee HC | Cancer Sci | 2023; 114(8):3301-3317 |
| 6 | Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma | Wang SF, Huang KW, Chou YC, Lee HC, Wu PK, Chen WM, Hung GY, Chang YL | Cancer Med | 2023;12(11):12354-64 |
| 7 | Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney disease | Hsu CC, Chen CC, Chou CY, Chen KH, Wang SF, Chang SL, Chang YL | J Thromb Thrombolysis | 2023;56(4)518-528 |
| 8 | Role of mitochondrial alterations in human cancer progression and cancer immunity | Wang SF, Tseng LM, Lee HC | J Biomed Sci | 2023;30(1)61 |
| 9 | Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation | Chiu HH, Chang SL, Cheng HM, Chao TF, Lin YJ, Lo LW, Hu YF, Chung FP, Liao JN, Tuan TC, Lin CY, Chang TY, Kuo L, Liu CM, Tasi YN, Huang YT, Chang YL, Wung JC, Chen SA | BMC Med Inform Decis Mak | 2023;23(1)163 |
| 10 | Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Chen CY, Pan SW, Hsu CC, Liu JJ, Kumamaru H, Dong YH | Respir Res | 2023;24(1)239 |
| 11 | Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan | Lai YH, Lee YC, Chen IR, Lin SN, Chang YL, Lu CC, Wu PF, Lin YT | J Microbiol Immunol Infect | 2023;56(6):1207-1213 |
| 12 | Association between Antihyperlipidemic Agent Use and Age-Related Macular Degeneration in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study | Chen CH, Lin HC, Lin HL, Keller JJ, Wang LH | Biomedicines | 2023;11(6):1508 |
| 13 | The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study | Tsai CJ, Lin YC, Chen CY, Hung CH, Lin YC | Biomedicines | 2023;11(9):2510 |
2023年非 SCI 論文
|
編號 |
篇名 |
作者 |
期刊 |
卷期 |
|---|---|---|---|---|
| 1 | 因應新冠疫情建置初階醫院藥學實習遠距教學模式 | 王明業、周千瀅 | 醫院藥學 | 2023; 40:1-8 |
| 2 | COVID-19大型防疫急門診藥事服務紀事 | 黃偉倫、王苾如、周千瀅、張豫立 | 醫院藥學 | 2023; 40:9-15 |
| 3 | 疑似Rosuvastatin引起橫紋肌溶解症 | 張立人、王斯郁 | 醫院藥學 | 2023; 40:16-22 |
| 4 | 急性骨髓性白血病伴隨FLT3-ITD突變之用藥探討 | 林子超、王笙帆、陳奇良 | 醫院藥學 | 2023; 40:23-31 |
| 5 | 叢發性頭痛藥物治療 | 黃冠慈、陳寬軒、朱佩欣 | 醫院藥學 | 2023; 40:32-40 |
| 6 | 惡性腫瘤併發高血鈣之治療 | 施立于、李婉詩 | 醫院藥學 | 2023; 40:41-45 |
| 7 | 骨質疏鬆之治療新藥-Romosozumab (Evenity®) | 吳汶儒、周千瀅 | 醫院藥學 | 2023; 40:46-49 |
| 8 | Tolvaptan-自體顯性多囊性腎臟病之新藥 | 吳建興、王笙帆、陳奇良 | 醫院藥學 | 2023; 40:50-53 |
| 9 | 寓教於樂，創新與運用科技增進教學能力-2022年臺北榮總藥學教育研討會紀實 | 周千瀅、蕭琦昀、王苾如、陳靜玟、于慧慈、張豫立 | 醫院藥學 | 2023; 40:57-65 |
| 10 | 雙免疫治療用於惡性肋膜間皮瘤之用藥探討 | 施立于、王笙帆、何沁沁 | 醫院藥學 | 2023; 40:66-76 |
| 11 | Warfarin併用Oseltamivir導致INR延長之病例用藥探討 | 吳建興、王笙帆、周千瀅 |
醫院藥學 | 2023; 40:77-83 |
| 12 | 阿茲海默症之藥物治療 | 黃冠慈、陳寬軒、朱佩欣 | 醫院藥學 | 2023; 40:84-92 |
| 13 | 卵巢癌治療新藥Niraparib | 吳汶儒、何沁沁 | 醫院藥學 | 2023; 40:93-97 |
| 14 | 憂鬱症病人的失眠藥物選用 | 陳靜玟、王笙帆、何沁沁 | 醫院藥學 | 2023; 40:98-103 |
| 15 | 抗生素於重症病人之藥物動力學與藥物效力學考量 | 黃偉倫、王笙帆、周千瀅 | 醫院藥學 | 2023; 40:104-111 |
| 16 | 使用呼吸器的ARDS重症病人於止痛藥與鎮靜劑之應用 | 周鈴雅、盧孟穗、周千瀅 | 醫院藥學 | 2023; 40:112-120 |
最後更新：